| Serial Number | 97539845 |
| Word Mark | ELSIE BIOTECHNOLOGIES |
| Filing Date | Monday, August 8, 2022 |
| Status | 730 - FIRST EXTENSION - GRANTED |
| Status Date | Monday, August 5, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, December 19, 2023 |
| Goods and Services | Custom manufacture of oligonucleotides |
| Goods and Services | Oligonucleotide compounds for use as pharmaceutical therapies prescribed or administered by a physician for the treatment of a wide variety of conditions and illnesses; Oligonucleotide delivery agents that facilitate delivery of a wide range of pharmaceutical therapies prescribed or administered by a physician; Oligonucleotide-based or -derived pharmaceuticals prescribed or administered by a physician for the treatment of a wide variety of conditions and illnesses; Pharmaceuticals prescribed or administered by a physician comprised of oligonucleotide compounds for the treatment of a wide variety of conditions and illnesses; Oligonucleotide delivery agents consisting of compounds that facilitate the delivery of a wide range of pharmaceutical and therapeutic agents prescribed or administered by a physician; drug delivery agents consisting of oligonucleotide compounds that facilitate delivery of a wide range of pharmaceuticals prescribed or administered by a physician |
| Goods and Services | Oligonucleotide compounds for use in the manufacture of pharmaceutical therapies |
| NOT AVAILABLE | "BIOTECHNOLOGIES" |
| Goods and Services | Research and development of oligonucleotide compounds for use in pharmaceutical therapies; Research and development of oligonucleotide delivery agents for use in pharmaceutical therapies; Research and development of oligonucleotide-based or -derived pharmaceuticals; Research and development of pharmaceuticals comprised of oligonucleotide compounds; Research and development of oligonucleotide delivery agents consisting of compounds that facilitate the delivery of a wide range of pharmaceutical and therapeutic agents; Research and development of drug delivery agents consisting of oligonucleotide compounds |
| International Class | 040 - Treatment of materials. |
| US Class Codes | 100, 103, 106 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, August 29, 2022 |
| Primary Code | 040 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry. |
| US Class Codes | 001, 005, 006, 010, 026, 046 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, September 27, 2023 |
| Primary Code | 001 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, August 29, 2022 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, August 29, 2022 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Elsie Biotechnologies Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | San Diego, CA 92121 |
| Party Name | Elsie Biotechnologies Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | San Diego, CA 92121 |
| Event Date | Event Description |
| Wednesday, May 24, 2023 | ASSIGNED TO EXAMINER |
| Thursday, August 11, 2022 | NEW APPLICATION ENTERED |
| Monday, August 29, 2022 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Thursday, June 29, 2023 | NON-FINAL ACTION WRITTEN |
| Thursday, June 29, 2023 | NON-FINAL ACTION E-MAILED |
| Thursday, June 29, 2023 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Wednesday, September 27, 2023 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Wednesday, September 27, 2023 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Wednesday, September 27, 2023 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Wednesday, November 29, 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Monday, November 13, 2023 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Tuesday, December 19, 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, December 19, 2023 | PUBLISHED FOR OPPOSITION |
| Monday, August 5, 2024 | SOU TEAS EXTENSION RECEIVED |
| Monday, August 5, 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Monday, August 5, 2024 | SOU EXTENSION 1 FILED |
| Monday, August 5, 2024 | SOU EXTENSION 1 GRANTED |
| Tuesday, February 13, 2024 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |